Article information
Full text is only aviable in PDF
Bibliografía
[1.]
A.M. Cooper, J. Fiynn.
The protective immune response to Mycobacterium tuberculosis.
Curr Opinion Immunol, 7 (1995), pp. 512-516
[2.]
L.B. Reichman.
Tuberculosis elimination -what's to stop us?.
Int J Tubero Lung Dis, 1 (1997), pp. 3-11
[3.]
N. Ait Khaled, D. Enarson, N. Billo.
The epidemiology of tuberculosis and of the resistance to antitubercular agents.
Rev Mal Respir, 14 (1997), pp. 8-18
[4.]
M.C. Raviglione, D.E. Snider, A. Kochi.
Global epidemiology of tuberculosis.
J Am Med Ass, 273 (1995), pp. 220-226
[5.]
R. Barnes.
Cytokine production in tuberculosis.
Tuberculosis, pp. 291-303
[6.]
B.E. Jones, S.M.M. Young, D. Antoniskis, T. Davidson, F. Dramer, P.F. Barnes.
Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection.
Am Rev Respir Dis, 148 (1993), pp. 1.292-1.297
[7.]
S.H. Kaufmann.
CD8+ T lymphocytes in intracellular microbial infections.
Immunol Today, 9 (1988), pp. 168-174
[8.]
J.L. Flynn, M.M. Goldstein, K.J. Trieboíd, B. Koller.
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.
Proc Natl Acad Sci USA, 89 (1992), pp. 1.203-1.217
[9.]
A. Lalvani, R. Brookes, R.J. Wilkinson, A.S. Malin, A.A. Pathan, P. Andersen, et al.
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.
Proc Natl Acad Sci USA, 95 (1998), pp. 270-275
[10.]
R.E. Tascon, E. Stavropoulos, K.V. Lukacs, M.J. Colston.
Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon.
Infect Immunol, 66 (1998), pp. 830-834
[11.]
M.E. Munk, M. Emoto.
Functions of T-cell subsets and cytokines in mycobacterial infections.
Eur Respir J, 20 (1995), pp. 668-675
[12.]
H.M. Surcel, M. Troye-Blomberg, S. Paulie, G. Anderson, C. Moreno, G. Pasvol, et al.
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens.
Immunology, 81 (1994), pp. 171-176
[13.]
M. Torres, T. Herrera, H. Villareal, E.A. Rich, E. Sada.
Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycohacterium tuberculosis.
Infect Immunol, 66 (1998), pp. 176-180
[14.]
T.I.A. Roach, C.H. Barton, D. Chatterjee, F.Y. Liew, J.M. Blackwell.
Opposing effects of interferon-γ and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages.
Immunology, 85 (1995), pp. 106-113
[15.]
S.H. Kaufmann, C.H. Ladel, I.E. Flesch.
T cells and cytokines in intracellular bacterial infections. Experiences with Mycobacterium bovis BCG.
Ciba Found Symp, 195 (1995), pp. 123-132
[16.]
A. Sodhi, J. Gong, C. Silva, D. Qian, P.F. Barnes.
Clinical correlates of interferon γ production in patients with tuberculosis.
Clin Infect Dis, 25 (1997), pp. 617-620
[17.]
R.A. Taha, T.C. Kotsimbos, Y.L. Song, D. Menzies, Q. Hamid.
IFN-γ and IL-12 are increased in active compared with inactive tuberculosis.
Am J Respir Crit Care Med, 155 (1997), pp. 1.135-1.139
[18.]
R. Condos, W.N. Rom, N.W. Schluger.
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol.
Lancet, 349 (1997), pp. 1.513-1.515
[19.]
D.K. Dalton, S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, T.A. Stewart.
Multiple defects of immune cell function in mice with disrupted interferon-γ genes.
Science, 259 (1993), pp. 1.739-1.742
[20.]
R. Kamijo, J. Le, D. Shapiro, E.A. Havell, S. Huang, M. Aguet, et al.
Mice that lack the interferon-γ receptor have profoundiy altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.
J Exp Med, 178 (1993), pp. 1.435-1.440
[21.]
M.J. Newport, C.M. Huxiey, S. Huston, C.M. Hawrylowicz, B.A. Oostra, R. Williamson, et al.
A Mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection.
N Engl J Med, 335 (1996), pp. 1.941-1.949
[22.]
E. Jouanguy, F. Altare, S. Lamhamedi, P. Revy, J.F. Emile, M. Levin, et al.
Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.
N Engl J Med, 335 (1996), pp. 1.956-1.961
[23.]
J. Yang, M. Mitsuyama.
An essential role for endogenous interferon-γ in the generation of protective T cells against Mycobacterium bovis BCG in mice.
Immunology, 91 (1997), pp. 529-535
[24.]
M.J. Fenton, M.W. Vermeulen, S. Kim, M. Burdick, R.M. Strieter, H. Komfeld.
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis.
Infect Immunol, 65 (1997), pp. 5.149-5.156
[25.]
G.F. Del Prete, M. De Carli, C. Mastromauro, R. Biagiotti, D. Macchia.
Purified Protein Derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (Type 1 T helper or Type 2 T helper) profile of cytokine production.
J Clin Invest, 88 (1991), pp. 346-350
[26.]
J. Haanen, R. Malefijt, P. Res, E. Kraakman, T. Ottenhoff, R. Vries.
Selection of a human T helper type 1-like T cell subset by Mycobacteria.
J Exp Med, 174 (1991), pp. 583-592
[27.]
A. Tsicopoulos, Q. Hamid, V. Varney, S. Ying, R. Moqbel, S. Durham, A. Kay.
Preferential messenger RNA expression of Th1-type cells (IFN-γ+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin.
J Immunol, 148 (1992), pp. 2.058-2.061
[28.]
W.H. Boom, R.S. Wallis, K.A. Chervenak.
Human Mycobacterium tuberculosis-reactiye CD4+ T-Cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes.
Infect Immunol, 59 (1991), pp. 2.737-2.743
[29.]
P.F. Barnes, J.S. Abrams, S. Lu, P.A. Sieling, T.H. Rea, R.L. Modlin.
Patterns of cytokine production by mycobacterium-reactive human T-cell clones.
Infect Immunol, 61 (1993), pp. 197-203
[30.]
P.F. Barnes, S. Lu, J.S. Abrams, E. Wang, M. Yamamura, R.L. Modlin.
Cytokine production at the site of disease in human tuberculosis.
Infect Immunol, 61 (1993), pp. 3.482-3.489
[31.]
V. Villena, A. López-Encuentra, J. Echave-Sustaeta, P. Martín-Escribano, B. Ortuño de Solo, J. Estenoz-Alfaro.
Interferon-γ in 388 immunocompromised and immunocompetent patients for diagnosing pleural tuberculosis.
Eur Respir J, 9 (1996), pp. 2.635-2.639
[32.]
F. Sánchez, J. Rodríguez, G. Agudelo, L. García.
Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.
Infect Immunol, 62 (1994), pp. 5.673-5.678
[33.]
M. Zhang, J. Gong, D.V. Lyer, B.E. Jones, R.L. Modlin, P.F. Bames.
T Cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection.
J Clin Invest, 94 (1994), pp. 2.435-2.442
[34.]
J.S. Rothel, S.L. Jones, L.A. Corner, J.C. Cox, P.R. Wood.
A sandwich enzyme immunoassay for bovine interferon-γ and its use for the detection of tuberculosis in cattie.
Aust Vet J, 67 (1990), pp. 134-137
[35.]
P.R. Wood, L.A. Corner, P. Plackett.
Development of a simple, rapid in vitro cellular assay for bovine tuberculosis based on the production of γ interferon.
Res Vet Sci, 49 (1990), pp. 46-49
[36.]
P.R. Wood, L.A. Corner, J.S. Rothel, C. Baldock, S.L. Jones, D.B. Cousins, et al.
Field comparison of the interferon-gamma assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis.
Aust Vet J, 68 (1991), pp. 286-290
[37.]
D.L. Whipple, C.A. Bolin, A.J. Davis, J.L. Jarnagin, D.C. Johnson, R.S. Nabors, et al.
Comparison of the sensitivity of the caudal fold skin test and a commercial γ-interferon assay for diagnosis of bovine tuberculosis.
Am J Vet Res, 56 (1995), pp. 415-419
[38.]
S.D. Neill, C.J. Hanna, D.P. Mackie, J.M. Pollock, A. Clements, E. Walton, et al.
Detection of Mycobacterium bovis infection in skin test-negative cattie with an assay for bovine interferon-gamma.
Vet Tec, 135 (1994), pp. 134-135
[39.]
M. Domingo, E. Liébana, J. Carrera, M. Vilafranca, J. Casal, A. Aranaz.
Eficacia comparativa de la intradermorreacción y de la prueba de liberación de γ-interferón para el diagnóstico de la tuberculosis bovina en una prueba de campo.
Med Vet, 12 (1995), pp. 307-317
[40.]
K.H. Ng, F.E. Aldwell, D.N. Wedlock, J.D. Watson, B.M. Buddle.
Antigen-induced interferon-γ and interleukin-2 responses of cattle inoculated with Mycobacterium bovis.
Vet Immunol Immunopathol, 57 (1997), pp. 59-68
[41.]
P.J. Converse, S.L. Jones, J. Astemborski, D. Vlahov, N. Graham.
Comparison of a tuberculin interferon-γ assay with the tuberculin skin test in high-risk adults: effect of human immunodeficienty virus infection.
J Infect Dis, 176 (1997), pp. 144-150
[42.]
J.A. Streeton, N. Desem, S.L. Jones.
QuantiFERON-TB: a new in vitro test for tuberculosis and atypical mycobacterial infection.
Am J Respir Crit Care Med, 151 (1995), pp. A511
[43.]
A.D. Lein, C.F. Von Reyn.
In vitro cellular and cytokine responses to mycobacterial antigens: application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines.
Am J Med Sci, 313 (1997), pp. 364-371
[44.]
R.L. Modlin, C. Pirmez, F.M. Hofman, V. Torigian, K. Uyemura, T.H. Rea, et al.
Lymphocytes bearing antigen specific γδ T-cell receptors accumulate in human infectious disease lesions.
Nature, 339 (1989), pp. 544-548
[45.]
R.L. Modlin, R. Barnes.
Gamma-Delta T cells and Mycobacterium.
Tuberculosis, pp. 329-334
[46.]
C.M. Parker, H. Groh, S.A. Band, C. Porcelli, C. Morita, M. Fabbi, et al.
Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire.
J Exp Med, 171 (1990), pp. 1.597
[47.]
F. Triebel, F. Faure, F. Mami-Chouaib, S. Jitsukawa, A. Griscelli, C. Genevee, et al.
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes.
Eur J Immunol, 18 (1988), pp. 2.021
[48.]
Y. Chien, R. Jores, M.P. Crowley.
Recognition by γ/δ T Cells.
Annu Rev Immunol, 14 (1996), pp. 511-532
[49.]
I. Tsuyuguchi, H. Kawasumi, C. Ueta, I. Yano, S. Kishimoto.
Increase of T-cell receptor γ/δ-bearing T cells in cord blood of newborn babies obtained by in vitro stimulation with mycobacterial cord factor.
Infect Immunol, 59 (1991), pp. 3.053-3.059
[50.]
G. Panchamoorthy, J. McLean, R.L. Modlin, C. Morita, S. Ishikawa, M.B. Brenner, et al.
A predominance of the T cell receptor Vγ2/Vδ2 subset in human mycobacteria-responsive T cells suggets germiine gene encoded recognition.
J Immunol, 147 (1991), pp. 3.360-3.369
[51.]
Y. Tanaka, C.T. Morita, Y. Tanaka, E. Nieves, M.B. Brenner, B.R. Bloom.
Natural and synthetic non-peptide antigens recognized by human γδ T cells.
Nature, 375 (1995), pp. 155-158
[52.]
V.E. García, P.A. Sieling, J. Gong, P.F. Barnes, K. Uyemura, Y. Tanaka, et al.
Single-Cell cytokine analysis of γδ T cell responses to nonpeptide mycobacterial antigens.
J Immunol, 159 (1997), pp. 1.328-1.335
[53.]
M. Fujita, Y. Miyachi, K. Nakata, S. Imamura.
γδ T-cell receptor-positive cells in human skin. I. Incidence and V-region gene expression in granulomatous skin lesions.
J Am Acad Dermatol, 28 (1993), pp. 46-50
[54.]
A. Tazi, I. Fajac, P. Soler, D. Valeyre, J.P. Battesti, A.J. Hance.
Gamma/Delta T-lymphocytes are not increased in number in granulomatous lesions of patients with tuberculosis or sarcoidosis.
Am Rev Respir Dis, 144 (1991), pp. 1.373-1.375
[55.]
G. Follows, M.E. Munk, A.J. Gatrill, P. Conradt, S.H.E. Kaufmann.
Gamma interferon and interleukin 2, but not interleukin 4, are detectable in γ/δ T-cell cultures after activation with bacteria.
Infect Immunol, 60 (1992), pp. 1.229-1.231
[56.]
C.H. Ladel, J. Hess, S. Daugelat, P. Mombaerts, S. Tonegawa, S.H.E. Daufmann.
Contribution of α/β and γ/δ T lymphocytes to immunity against Mycobacterium bovis Bacillus Calmette Guérin: studies with T cell receptor-deficient mutant mice.
Eur J Immunol, 25 (1995), pp. 838-846
[57.]
M.E. Munk, A.J. Gatrill, S.H.E. Kaufmann.
Target cell lysis and IL-2 secretion by γ/δ T lymphocytes after activation with bacteria.
J Immunol, 145 (1990), pp. 2.434-2.439
[58.]
C.D. D'Souza, A.M. Cooper, A.A. Frank, R.J. Mazzaccaro, B.R. Bloom, I.M. Orme.
An anti-inflamatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis.
J Immunol, 158 (1997), pp. 1.217-1.221
[59.]
K. Tsukaguchi, K.N. Balaji, W.H. Boom.
CD4+ αβ T cell and γδ T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production.
J Immunol, 154 (1995), pp. 1.786-1.796
[60.]
K.B. Pfeffer, B. Schoel, H. Gulle, S.H. Kaufmann, H. Vagner.
Primary responses of human T cells to mycobacteria: a frequent set of gamma/delta T cells are stimulated by protease-resistant ligands.
Eur J Immunol, 20 (1990), pp. 1.175
[61.]
W.H. Boom, K.N. Balaji, R. Nayak, K. Tsukaguchi, K.A. Chervenak.
Characterization of a 10- to 14- Kilodalton protease-sensitive Mycobacterium tuberculosis H37Ra antigen that stimulates human γδ T cells.
Infect Immunol, 62 (1994), pp. 5.511-5.518
[62.]
F. Lang, M.A. Peyrat, P. Constant, F. Davodeau, J. Dvid-Ameline, Y. Poquet, et al.
Early Activation of human Vγ9Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands.
J Immunol, 154 (1995), pp. 5.986-5.994
[63.]
P. Constant, F. Davodeau, M.A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, et al.
Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands.
Science, 264 (1994), pp. 267-270
[64.]
P. Constant, Y. Poquet, M.A. Peyrat, F. Davodeau, M. Bonneville, J.J. Fournié.
The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated nonpeptidic antigens for human γδ T cells.
Infect Immunol, 63 (1995), pp. 4.628-4.633
[65.]
H. Li, M.I. Lebedeva, A.S. Llera, B.A. Fields, M.B. Brenner, R.A. Mariuzza.
Structure of the Vdelta domain of a human gamma-delta T-cell antigen receptor.
Nature, 391 (1998), pp. 502-506
[66.]
K. Pechhold, D. Wesch, S. Schondelmaier, D. Kabelitz.
Primary activation of Vγ9-expressing γδ T cells by Mycobacterium tuberculosis.
J Immunol, 152 (1994), pp. 4.984-4.992
[67.]
D. Wesch, S. Marx, D. Kabelitz.
Comparative analysis of αβ and γδ T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate.
Eur J Immunol, 27 (1997), pp. 952-956
[68.]
D. Wesch, D. Kabelitz, K. Friese, K. Pechhold.
Mycobacteria-reactive γδ T cells in HIV-infected individuais: lack of Vγ9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells.
Eur J Immunol, 26 (1996), pp. 557-562
[69.]
M. López-Botet, M. Carretero, T. Bellón, J.J. Pérez-Villar, M. Llano, F. Navarro.
The CD94/NKG2 C-type lectin receptor complex.
Curr Top Microbiol Immunol, 230 (1998), pp. 41-52
[70.]
I. Carena, A. Shamshiev, A. Donda, M. Colonna, G. De Libero.
Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-γ/δ Stimulated by nonpeptidic ligands.
J Exp Med, 186 (1997), pp. 1.769-1.774
[71.]
L. Battistini, G. Borselino, G. Swicki, F. Poccia, M. Salvetti, G. Ristori, et al.
Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing NK cell receptors.
J Immunol, 159 (1997), pp. 3.723-3.730
[72.]
F. Poccia, B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, et al.
CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V-γ9Vδ2 T lymphocytes.
J Immunol, 159 (1997), pp. 6.009-6.017
[73.]
F. Halary, M.A. Peyrat, E. Champagne, M. López-Botet, A. Moretta, L. Moretta, et al.
Control of self-reactive cytotoxic T lymphocytes expressing γδ T cell receptors by natural killer inhibitory receptors.
Eur J Immunol, 27 (1997), pp. 2.812-2.821
[74.]
M. Colonna, F. Navarro, T. Bellón, M. Llano, P. García, J. Samaridis, et al.
A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.
J Exp Med, 186 (1997), pp. 1.809-1.818
[75.]
P. Fisch, E. Meuer, D. Pende, S. Rothenfusser, O. Viale, S. Koch, et al.
Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
Eur J immunol, 27 (1997), pp. 3.368-3.379
[76.]
B. Falini, L. Flenghi, S. Pileri, P. Pelicci, M. Fagioli, M.F. Martelli, et al.
Distribution of T cells bearing different forms of the T cell receptor γ/δ in normal and pathological human tissues.
J Immunol, 143 (1989), pp. 2.480-2.488
[77.]
P.F. Barnes, C.L. Grisso, J.S. Abrams, H. Band, T.H. Rea, R.L. Modlin.
γδ T lymphocytes in human tuberculosis.
J Infect Dis, 146 (1992), pp. 1.216-1.221
[78.]
C. Ueta, I. Tsuyuguchi, H. Kawasumi, T. Takashima, H. Toba, S. Kishimoto.
Increase of γ/δ T cells in hospital workers who are in ciose contact with tuberculosis patients.
Infect Immunol, 62 (1994), pp. 5.434-5.441
[79.]
B. Li, M.D. Rossman, T. Imir, A.F. Oner-Eyuboglu, C. Lee, R. Biancaniello, et al.
Disease-specific changes in γδ T cell repertoire and function in patients with pulmonary tuberculosis.
I Immunol, 157 (1996), pp. 4.222-4.229
[80.]
M. Ito, N. Kojiro, T. Ikeda, T. Ito, J. Fuñada, T. Kokubu.
Increased proportions of peripheral blood γδ T cells in patients with pulmonary tuberculosis.
Chest, 102 (1992), pp. 195-197
[81.]
A. Tazi, F. Bouchonnet, D. Valeyre, I. Cadranel, J.P. Battesti, A.I. Hance.
Characterization of γ/δ T-lymphocytes in the peripheral blood of patients with active tuberculosis.
Am Rev Respir Dis, 148 (1992), pp. 1.216-1.221
[82.]
Z. Balikó, L. Szereday, J. Szekeres-Bartho.
γ/δ T lymphocytes in Mycobacterium tuberculosis infection.
Thorax, 52 (1997), pp. 375-377
[83.]
F. Poccia, S. Boullier, H. Lecoeur, M. Cochet, Y. Poquet, V. Colizzi, et al.
Peripheral Vγ9/Vδ2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1 infected persons.
J Immunol, 157 (1996), pp. 449-461
[84.]
K.A. Chevernak, M.M. Lederman, W.H. Boom.
Bacterial antigen activation of Vδ1 and Vδ2 γδ T cells of persons infected with human immunodeficiency virus type I.
J Infect Dis, 175 (1997), pp. 429-433
Copyright © 1998. Sociedad Española de Neumología y Cirugía Torácica
